Back
Entrada Therapeutics Stock Price Chart
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
TRDA
Entrada Therapeutics
Last Price:
14.68
Seasonality Move:
13.84%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing slight buying pressure.
Entrada Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.6 | Buy |
| 20-day SMA: | 15.54 | Sell |
| 50-day SMA: | 15.95 | Sell |
| 200-day SMA: | 14.68 | Buy |
| 8-day EMA: | 14.67 | Buy |
| 20-day EMA: | 15.18 | Sell |
| 50-day EMA: | 15.47 | Sell |
| 200-day EMA: | 14.99 | Buy |
Entrada Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 47.36 | Sell |
| Chaikin Money Flow: | 57001 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.69 - 16.79) | Sell |
| Bollinger Bands (100): | (14.13 - 16.59) | Sell |
Entrada Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Entrada Therapeutics Stock
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 15.00 while TRDA 8-day simple moving average is 14.60, which is a Buy signal.
- The stock price of TRDA is 15.00 while Entrada Therapeutics 20-day SMA is 15.54, which makes it a Sell.
- Entrada Therapeutics 50-day simple moving average is 15.95 while TRDA share price is 15.00, making it a Sell technically.
- TRDA stock price is 15.00 and Entrada Therapeutics 200-day simple moving average is 14.68, creating a Buy signal.
TRDA Technical Analysis vs Fundamental Analysis
Buy
51
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy or a Sell?
-
Entrada Therapeutics stock is rated a Buy
The current Entrada Therapeutics [TRDA] share price is $15.00. The Score for TRDA is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Entrada Therapeutics Stock Info
Market Cap:
557.99M
Price in USD:
15.00
Share Volume:
137.97K
Entrada Therapeutics 52-Week Range
52-Week High:
18.17
52-Week Low:
10.75
Buy
51
Entrada Therapeutics (TRDA)
is a Buy
Entrada Therapeutics Share Price Forecast
-
What is the Entrada Therapeutics stock price today?
The Entrada Therapeutics stock price is 15.00 USD today. -
Will TRDA stock go up or go down?
Entrada Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Entrada Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entrada Therapeutics is not overvalued.
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 15.00 while TRDA 8-day exponential moving average is 14.67, which is a Buy signal.
- The stock price of TRDA is 15.00 while Entrada Therapeutics 20-day EMA is 15.18, which makes it a Sell.
- Entrada Therapeutics 50-day exponential moving average is 15.47 while TRDA share price is 15.00, making it a Sell technically.
- TRDA stock price is 15.00 and Entrada Therapeutics 200-day simple moving average is 14.99, creating a Buy signal.
Fundamental Analysis of Entrada Therapeutics
Is Entrada Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.35 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.
Technical Analysis of Entrada Therapeutics
Should I short Entrada Therapeutics stock?
- TRDA Moving Average Covergence Divergence (MACD) indicator is -0.43, suggesting Entrada Therapeutics is a Sell
- Entrada Therapeutics Relative Strength Index (RSI) is 47.36, which suggest Entrada Therapeutics is oversold
- The Bollinger Bands (25) for Entrada Therapeutics is (14.69 - 16.79), which suggest Entrada Therapeutics is a Sell
- The Bollinger Bands (100) for Entrada Therapeutics is (14.13 - 16.59), which suggest Entrada Therapeutics is a Sell
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.